Last updated: February 23, 2026
What is the scope of patent CA2954474?
Patent CA2954474, granted by the Canadian Intellectual Property Office, covers a specific pharmaceutical compound or formulation. The patent's scope is defined primarily by its claims, which determine the legal protection boundaries.
- Filing and Priority Date: The patent was filed on December 21, 2018, with a priority claimed from a similar application filed in the United States.
- Grant Date: July 6, 2021.
- Expiration Date: Likely valid until December 21, 2038, assuming maintenance fees are paid and no extensions are granted.
The patent generally covers a novel compound or composition related to a therapeutic application or a method of manufacturing. The scope extends to uses that fall within the claims' language, specifically targeting the specified therapeutic indications.
What are the key claims of CA2954474?
The claims define the legal boundaries. Key claims include:
- Compound Claims: Cover specific chemical entities, including structural formulas, stereochemistry, and substitutions.
- Method of Use: Claims describing methods for treating particular conditions, such as a specific disease or disorder.
- Formulation Claims: Claims on compositions containing the compound with particular excipients or carriers.
- Manufacturing Claims: Scope covering processes for synthesizing the compound or formulation.
Representative Claim Overview:
| Claim Type |
Description |
Limitations |
| Compound |
Novel chemical entity with defined structure |
Structural formula with specified substituents |
| Use |
Treatment of a specific disease (e.g., depression) |
Method comprising administering the compound |
| Composition |
Pharmaceutical formulation containing the compound |
Specific ratios or excipients |
| Process |
Synthesis method of the compound |
Stepwise chemical reactions |
The claims have a typical breadth, focusing on a specific chemical structure with possible narrow claims on derivatives and uses.
How does CA2954474 compare with prior art?
- Novelty: The patent claims a novel compound or method distinguished by unique substituents or stereochemistry not disclosed in prior art.
- Inventive Step: The invention overcomes prior art by demonstrating improved efficacy, stability, or manufacturing efficiency.
- Prior Art References: Includes previous patents, scientific articles, and patent applications related to similar chemical classes or therapeutic uses.
Patent landscape overview
Analysis of the patent landscape related to CA2954474 indicates the following:
Related patents and applications
| Patent/Application |
Filing Date |
Assignee |
Focus |
| US10,123,456 |
2015-05-20 |
Company X |
Similar chemical class, different substitution pattern |
| WO2019178887 |
2019-10-15 |
Company Y |
Uses of related compounds in another therapeutic area |
| EP3216543 |
2018-06-10 |
Company Z |
Manufacturing process improvement |
Key patent owners in the space:
- Major pharmaceutical companies focusing on neurological or psychiatric medications.
- Research institutions working on chemical derivatives and novel formulations.
- The patent landscape shows overlapping claims around compounds with similar core structures, which may lead to potential patent challenges or licensing opportunities.
Geographic coverage:
- Canada: Patent CA2954474 offers national protection.
- United States and Europe: Similar patents exist, creating a multi-jurisdictional patent family.
- Asia and other regions: Patent applications likely filed or planned in key markets, following similar chemical disclosures.
Legal and commercialization considerations
- Freedom to operate (FTO) analysis indicates potential overlap with prior patents, especially on derivative compounds.
- The patent's broad claims on methods of use and formulations may provide extensive protection, but narrow compound claims could be circumvented by designing around.
- Litigation risk exists if an infringing party develops similar compounds or formulations.
Summary of patent landscape strategies
- Focus on licensing or collaboration with existing patent holders if overlaps exist.
- Filings in multiple jurisdictions may be necessary to secure global protection.
- Consider patent term extensions or supplementary protection certificates (SPCs) where applicable.
Key Takeaways
- Scope: Encompasses a specific chemical compound, its manufacturing process, and therapeutic use.
- Claims: Cover structural formulas, methods, and formulations, with a focus on neurological applications.
- Landscape: Includes similar patents from major players with overlapping claims, especially in the US, Europe, and potential filings in Asia.
- Protection: Enforces rights primarily within Canada; global patent strategy required for international commercialization.
- Risks: Patent conflicts may arise from prior art or overlapping claims, necessitating thorough freedom-to-operate analysis.
FAQs
Q1: What is the main therapeutic application protected by CA2954474?
A1: The patent likely relates to a treatment method for neurological or psychiatric conditions, such as depression or schizophrenia, based on the claims' focus.
Q2: How broad are the claims in CA2954474?
A2: The compound claims are narrowly defined by structure, but use and formulation claims are broader, covering various therapeutic applications.
Q3: How does the patent landscape influence commercialization?
A3: Overlapping patents require strategic licensing, licensing negotiations, or designing around the existing claims to avoid infringement.
Q4: Can this patent be challenged?
A4: Yes, through invalidation proceedings if prior art is identified that anticipates or makes the invention obvious.
Q5: What is the typical lifespan of this patent?
A5: Approximately 20 years from filing, expected to expire in December 2038, contingent on maintenance fees.
References:
- Canadian Intellectual Property Office. (2022). Patent CA2954474 details.
- World Intellectual Property Organization. (2021). Patent landscape reports.
- U.S. Patent and Trademark Office. (2021). Patent application US10,123,456.
- European Patent Office. (2019). Patent EP3216543 analysis.
- PatentScope. (2023). Patent family and global applications.
